0001209191-21-024636.txt : 20210402
0001209191-21-024636.hdr.sgml : 20210402
20210402164157
ACCESSION NUMBER: 0001209191-21-024636
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210329
FILED AS OF DATE: 20210402
DATE AS OF CHANGE: 20210402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Russo Thomas Joseph
CENTRAL INDEX KEY: 0001791973
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35005
FILM NUMBER: 21802500
MAIL ADDRESS:
STREET 1: C/O ASSEMBLY BIOSCIENCES, INC.
STREET 2: 11711 N MERIDIAN ST, SUITE 310
CITY: CARMEL
STATE: IN
ZIP: 46032
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ASSEMBLY BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001426800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 331 OYSTER POINT BLVD.
STREET 2: FOURTH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (833) 409-4583
MAIL ADDRESS:
STREET 1: 331 OYSTER POINT BLVD.
STREET 2: FOURTH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: VENTRUS BIOSCIENCES INC
DATE OF NAME CHANGE: 20080211
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-29
0
0001426800
ASSEMBLY BIOSCIENCES, INC.
ASMB
0001791973
Russo Thomas Joseph
C/O ASSEMBLY BIOSCIENCES, INC.
331 OYSTER POINT BLVD., FOURTH FLOOR
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
CFO
Common Stock
2021-03-29
4
A
0
11250
0.00
A
54633
D
Stock Option (right to buy)
4.33
2021-03-29
4
A
0
67500
0.00
A
2031-03-29
Common Stock
67500
67500
D
Grant of restricted stock units. The restricted stock units vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2022; March 29, 2023; March 29, 2024; and March 29, 2025.
Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2022; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2025.
/s/ John O. Gunderson, as Attorney-in-Fact
2021-04-02